Relmada Therapeutics Inc (RLMD) - Forvard narx/daromad multiplikatori
Relmada Therapeutics (RLMD) tadqiqot va ishlanmalar (R&D) moslashuvchanligini saqlab qolish uchun ishlab chiqarish va sinovlarni autsorsing qilishga tayanadi. FDA ning qat'iy nazorati ostidagi REL-1017 patentlari bozorga kirish uchun yuqori to'siqlarni yaratadi. Kompaniyaning taqdiri sinovlarning muvaffaqiyati va kapital xarajatlar sur'atiga bog'liq. Ushbu kelajakdagi sotuvlarga nisbatan narx ko'rsatkichi grafigi ushbu tendentsiyalarni vizuallashtiradi va joriy ko'rsatkich darajasiga yetdi.
Relmada Corp (RLMD) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi ko'rsatkichlari:
- biznesning balans baholash tafsilotlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning xususiy kapitalga nisbati Relmada Therapeutics|RLMD - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning kapitalga nisbati Relmada Therapeutics|RLMD - Kompaniyaning jamlangan qarzlari|Qarzning balans kapitallashuviga nisbati Relmada Corp|RLMD - Uzoq muddatli majburiyatlar|Kompaniyaning qisqa muddatli qarzlari Relmada Therapeutics|Tezkor likvidlik ko‘rsatkichi relmada.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
RLMD - Sof foyda|Kelajakdagi foyda Relmada Therapeutics|RLMD - Bozor narxining sof foydaga nisbati|Forvard P/E multiplikatori Relmada|RLMD - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|EV/EBITDA multiplikatori Relmada Corp|RLMD - Eskirish chegirilmasdan oldingi operatsion foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foyda Relmada Therapeutics|RLMD - So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi relmada.com|RLMD - Joriy yilda bir aksiya uchun foyda ortishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi Relmada Therapeutics
- kompaniyaning sotuvlari va tushumi statistikasi:
Kompaniyaning fundamental tahlili:RLMD (Relmada Therapeutics, Inc.)
Ushbu koeffitsient dinamikasi bozorning kelgusidagi sotuvlar va tashqi sharoitlar o'zgarishi sharoitida biznesning o'z kapitalizatsiyasini saqlab qolish qobiliyatiga bo'lgan kutganlarini aks ettiradi. Relmada Therapeutics (RLMD) klinik sinovlar bosqichida ekanligi va hozirda daromadga ega emasligi sababli, kompaniyaning forward P/S grafigi potentsial daromadning spekulyativ baholashini ko'rsatadi, bu esa hozirda butunlay tashqi kapitalni jalb qilish samaradorligiga bog'liqdir.
Toʻgʻridan-toʻgʻri raqobatchilar
Biogen - Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx NBIX|RGC: Forvard narx/daromad multiplikatori|Axsome Corp - Narxning kutilayotgan daromadga nisbati|ACAD: Forvard P/S multiplikatori|xenon-pharma.com - Sotuvga nisbatan forvard narx|VKTX (Viking Therapeutics, Inc.) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Supernus Pharmaceuticals, Inc. SUPN|Narxning prognoz qilingan daromadga nisbati Catalyst Pharmaceuticals Inc (CPRX)|DNLI (Denali Corp) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori HRMY (Harmony Biosciences)|Forvard P/S multiplikatori biohavenpharma.com BHVN|AMLX - Narxning prognoz qilingan daromadga nisbati|Kelajakdagi narxning daromadga nisbati TRVI|PRAX: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Anavex Life Sciences Corp (AVXL)|Forvard narx/daromad multiplikatori CBLL|Forvard P/S multiplikatori Prothena Corporation|Forvard narx/daromad multiplikatori ALEC (Alector, Inc.)|Narxning kutilayotgan daromadga nisbati ANNX|Forvard P/S multiplikatori OMER (Omeros)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Neurogene Therapeutics (NGNE)|AC Immune - Forvard P/S multiplikatori|voyagertherapeutics.com (VYGR) - Forvard narx/daromad multiplikatori|Neumora Therapeutics, Inc. (NMRA) - Narxning prognoz qilingan daromadga nisbati|SCLX - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Tevogen Bio Holdings, Inc.|ACOG: Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Cognition Therapeutics (CGTX)|Narxning prognoz qilingan daromadga nisbati IKT (inhibikase.com)|Narxning prognoz qilingan daromadga nisbati Cassava Sciences SAVA|ASRT - Forvard narx/daromad multiplikatori|Coya - Forvard P/S multiplikatori|VTGN (Vistagen Therapeutics) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|ovidrx.com (OVID) - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning prognoz qilingan daromadga nisbati ABOS|CRVO (CervoMed) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Alterity Therapeutics Ltd ATHE|Forvard narx/daromad multiplikatori CLNN (Clene Inc.)|Forvard P/S multiplikatori pepgen.com (PEPG)|Narxning prognoz qilingan daromadga nisbati Jupiter Neurosciences Inc JUNS|Sotuvga nisbatan forvard narx ANVS|GRCE - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati Firefly Neuroscience, Inc.|anewmeds.com (KLTO) - Narxning prognoz qilingan daromadga nisbati|NeuroSense Therapeutics Ltd. - Sotuvga nisbatan forvard narx|RVPH (Reviva Pharmaceuticals) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati MetaVia, Inc. MTVA|Narxning prognoz qilingan daromadga nisbati NeurAxis (NRXS)|Narxning prognoz qilingan daromadga nisbati HSDT (heliusmedical.com)|Narxning prognoz qilingan daromadga nisbati Passage Bio PASG|NEUP - Forvard narx/daromad multiplikatori|Minerva Neurosciences - Forvard P/S multiplikatori|ATHA - Forvard P/S multiplikatori|ADXN: Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati ALZN|CYCN (Cyclerion Therapeutics Inc.) - Forvard P/S multiplikatori|Forvard P/S multiplikatori Protagenic|Forvard narx/daromad multiplikatori KTTA (Pasithea Therapeutics)|CRGT (cortigent.com) - Sotuvga nisbatan forvard narx|Avenue Therapeutics, Inc. - Forvard narx/daromad multiplikatori|Narxning kutilayotgan daromadga nisbati BCLI (Brainstorm Cell Therapeutics Inc.)|Cara Therapeutics, Inc - Forvard P/S multiplikatori|Sotuvga nisbatan forvard narx CHRO (Chromocell)|ELYM: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Intra-Cellular Therapies, Inc. (ITCI)|Narxning prognoz qilingan daromadga nisbati Longboard Pharmaceuticals, Inc.|MRNS: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori NKGN|Forvard P/S multiplikatori NeuroBo Pharma (NRBO)|Narxning prognoz qilingan daromadga nisbati Sage Therapeutics, Inc. SAGE|SNPX (synaptogen.com) - Kelajakdagi narxning daromadga nisbati|Trevena - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Vigil Neuroscience|WENA (Anew Medical) - Forvard narx/daromad multiplikatori|Cerevel Corp (CERE) - Forvard P/S multiplikatori
